Mydecine's research agreement with the University of Alberta gives the company a Health Canada-licensed platform from which to base its research. #psychedelics #psychedelicsstocks #stocks $MYCO $NLBIF #health #healthcare #psilocybin https://t.co/07CBHIAMnm